Mark Steinberg, MD
Oral and Maxillofacial Pathology · Maywood, ILNPI 1477622801
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $8,172 of the $12,904 with a category attached, or 63.3%. Southern Implants North America Inc accounts for 84.6% of it on its own, with 8 other manufacturers making up the rest. Reporting peaked in 2024 at $9,282 and has fallen 98.4% since, to $150 in 2025.
Across 50 payments — averaging $258.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Southern Implants North America Inc$11K
- Zimvie Inc.$1K
- Henry Schein, Inc.$500
- Johnson & Johnson$110
- Dentsply Sirona Inc$91
- Kls-martin L.p.$62
- plus $60 from 3 others
What the payments were for
- Speaking & faculty fees$2,00015%
- Travel & lodging$8,17263%
- Food & beverage$2,73221%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Southern Implants North America Inc | 32 | $10,915 |
| Zimvie Inc. | 8 | $1,166 |
| Henry Schein, Inc. | 1 | $500 |
| Johnson & Johnson | 2 | $110 |
| Dentsply Sirona Inc | 1 | $91 |
| Kls-martin L.p. | 2 | $62 |
| Geistlich Pharma, North America, Inc. | 2 | $25 |
| Biohorizons Implant Systems Inc. | 1 | $18 |
| Benco Dental Supply Co. | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Inverta$8,991
- Provata$1,708
- Tapered Screw-Vent$1,014
- TRI-MAX$516
How this compares
Too few oral and maxillofacial pathology providers in Illinoisto place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Amoxicillin | 292 | $1,040 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 150 | $921 |
| Acetaminophen-CodeineAcetaminophen With Codeine | 93 | $588 |
| Chlorhexidine Gluconate | 91 | $492 |
| Clindamycin Hcl | 62 | $366 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 23 | $169 |
| Azithromycin | 12 | $60 |
| Ibuprofen | 17 | $26 |
Paid to pharmacies, not to this prescriber.
Other oral and maxillofacial pathology in Maywood
- David EfawBloomington$2K
- Jack CapodiceBloomington$1K
- Thomas OcheltreeBloomington$1K
- Allan LibunaoBolingbrook$639
- Michael GuthrieChicago$530
- Jerome SchoenBarrington$214
- Gregory DoerflerGlen Ellyn$195
- Martin ZidronDeer Park$168
- Glenn ScheiveBloomingdale$57
- Dennis BoyerBloomingdale$56
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.